Paul Derose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NIST is establishing a Flow Cytometry Standards Consortium to accelerate the adoption of quantitative flow cytometry in biomanufacturing of cell ad gene therapies. The purpose of this workshop is to launch and inform future directions of the Flow Cytometry Standards Consortium. Participants will learn about state-of-the-art in flow cytometry applications, help to identify pressing measurement challenges and standards needs, and provide initial feedback on the proposed directions of the Consortium. Future meetings of the Consortium will further refine and implement Consortium plans.  

Credit: B. Hayes/NIST Advances in cell and gene therapies are revolutionizing health care by providing curative treatments for previously untreatable diseases. To help develop standards and measurements to support the discovery and manufacture of these groundbreaking therapies, NIST is launching the Flow Cytometry Standards Consortium. Beginning with a workshop the afternoons of Feb. 16 and 17, the consortium will convene stakeholders in the health care and biotechnology communities to solve common measurement problems related to this technology. We sat down with National Institute...